COMPOUNDS AND COMPOSITIONS AND USES THEREOF

COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER

CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS

COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER

COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER

COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER

SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF

COMPOUNDS AND COMPOSITIONS AND USES THEREOF

ISOCHROMAN DERIVATIVES AND COMPOSITIONS AND USES THEREOF

COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF

NOVEL USE OF SUBSTITUTED 2H-CHROMENS AND THEIR DERIVATIVES

Compounds and compositions and uses thereof

Substituted bicyclic compounds

SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF

NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF

SMALL MOLECULES AGAINST CANCER

Compound as PPAR agonist and application thereof

Process for the preparation of 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazole and the hydrogensulfate salt thereof

Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Substituted bicyclic compounds

Small molecules against cancer

Triazoles as Kv3 inhibitors

Nebivolol synthesis method and intermediate compound thereof

Compounds and compositions and uses thereof

Glucosylceramide synthase inhibitors for the treatment of diseases

Small molecules against cancer

Carbon dioxide as a directing group for C—H functionalization reactions involving Lewis basic amines, alcohols, thiols, and phosphines for the synthesis of compounds

METHOD FOR EXTRACTING ACTIVE INGREDIENTS

Dibromo-diiodo-dipolycyclic compound and electron acceptor molecules derived therefrom

Manganese (III) catalyzed C—H aminations

Substituted bicyclic compounds

3-Phenyl-7-Hydroxy-Isocoumarins as Macrophage Migration Inhibitory Factor (MIF) Inhibitors

Triazoles as Kv3 inhibitors

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

Nebivolol synthesis method and intermediate compound thereof

Glucosylceramide synthase inhibitors for the treatment of diseases

Compounds and compositions and uses thereof

Compounds and compositions and uses thereof

Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device

Dibromo-diiodo-dipolycyclic compound and electron acceptor molecules derived therefrom

Modulation of Dopamine Receptor to Promote Neural Cell Differentiation

Substituted bicyclic compounds

Benzenesulfonyl-asymmetric ureas and medical uses thereof

SOLID ACID CATALYST AND METHOD FOR PRODUCING OXIDE

Chiral diamine compounds for the preparation of chiral alcohols and chiral amines

3-phenyl-7-hydroxy-isocoumarins as macrophage migration inhibitory factor (MIF) inhibitors

LXR agonists and uses thereof

Substituted bicyclic compounds

Triazoles as KV3 inhibitors

Process for the synthesis of carboxylic acid derivatives

Substituted bicyclic compounds

Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins

Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors

GRAPE EXTRACT, DIETARY SUPPLEMENT THEREOF, AND PROCESSES THEREFOR

Hydantoin derivatives as Kv3 inhibitors

Compounds for treating spinal muscular atrophy

Bicyclic compound

Triazoles as Kv3 inhibitors

Hydantoin derivatives as KV3 inhibitors

Benzopyrone estrogen receptor regulator

Process for the preparation of atovaquone

Enantioselective organic anhydride reactions

Inhibitors of the renal outer medullary potassium channel

PRODUCTION OF LIPOXYGENASE INHIBITORS VIA FUNGAL BIOSYNTHETIC PATHWAY

Process for synthesizing epicconone analogs

TRPA1 antagonists

Compound having hydrocoumarin skeleton, liquid crystal compostition, and liquid crystal display device

TETRAHYDRONAPHTHALENE DERIVATES, PROCESS FOR PREPARING THEM AND THEIR USE AS ANTIINFLAMMATORY AGENTS

TRYPHOSTIN-ANALOGS FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES

PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE

Fluoroboron compound having aromatic ring or salt thereof, and method for producing compound having cyclic ether-fused aromatic ring using the same

Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient

Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device

OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS

ANDROGEN MODULATORS

METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID

Substituted heterocyclic ethers and their use in CNS disorders

Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use

COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA

Substituted Ureas and Carbamates

Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof

Palladacycles, Their Preparation and Catalytic Processes Involving Their Use as Catalyst, Especially Catalytic Carbonylation Processes

Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof

Bicyclic carboxylic acid derivatives useful for treating metabolic disorders

Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Androgen modulators

Dpp-iv inhibitors

2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers

Isocoumarin-based inhibitors of urokinase-type plasminogen activator

Monoamine re-uptake inhibitors and methods relating thereto

Process for preparation of isochroman and derivatives thereof

Chemical process

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Urotensin II receptor agents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

2-amino- and 2-thio- substituted 1,3-diaminopropanes

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Benzopyran analogs and their use for the treatment of glaucoma

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof

Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists

Rearranged pentanols, a process for their production and their use as anti-inflammatory agents

Process for preparing homophthalate derivatives

Isochroman compounds for treatment of CNS disorders

Method for isolation of bulk anthocyanidins and other bioactives